TheraRadar
← Back
Data updated: Mar 29, 2026

RENATA

CardiovascularNeurology
Generics

RENATA is a generic drug manufacturer focused on Cardiovascular, Neurology.

1995
Since
5
Drugs
-
Trials
125
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

METOLAZONE 2026-01-07
Manufacturing (CMC)
RISPERIDONE 2025-11-04
Labeling
METOPROLOL TARTRATE 2025-09-15
Labeling
RISPERIDONE 2025-09-11
Labeling
METOPROLOL TARTRATE 2025-09-03
Labeling
METOPROLOL TARTRATE 2025-09-03
Labeling
METOPROLOL TARTRATE 2025-09-03
Labeling
RISPERIDONE 2025-09-02
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 67%
2 drugs
Neurology 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

GE HEALTHCARE specialty
Neurology, Cardiovascular
Novo Nordisk big-pharma
Cardiovascular, Neurology
LEDERLE big-pharma
Cardiovascular, Neurology
PAI HOLDINGS PHARM big-pharma
Neurology, Cardiovascular
VALIDUS PHARMS specialty
Cardiovascular, Neurology